Literature DB >> 19005379

Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients.

Ioannis Stavrou1, Christoph Baumgartner, Josa M Frischer, Siegfried Trattnig, Engelbert Knosp.   

Abstract

OBJECTIVE: The goal of this study was to examine the long-term outcomes of 53 epilepsy patients who were surgically treated for supratentorial cavernomas in a single-center study and to assess both the duration of epilepsy and the resection of the hemosiderin rim for their prognostic relevance during extended follow-up.
METHODS: Fifty-three patients underwent microsurgical resection of radiologically diagnosed supratentorial cavernomas. For the outcome analysis, they were divided into 2 groups: Group A (33 patients) with a preoperative duration of epilepsy of less than 2 years, and Group B (20 patients) with a preoperative duration of epilepsy of 2 years or more. The natural history of the cavernomas, localization and size of the lesions, use of antiepileptic drugs, surgery timing, and technique (removal or not of the surrounding gliosis) were evaluated retrospectively. The outcome of epilepsy was based on Engel's classification and the International League Against Epilepsy classification.
RESULTS: After a mean follow-up period of 8.1 years, 45 (84.9%) of the 53 patients were free from disabling seizures (Engel Class I), including 37 patients (69.8%) who were completely free of postoperative seizures (Engel Class IA); 43 patients (81.1%) were categorized as International League Against Epilepsy Class 1. Outcome was statistically significantly improved in the patient subgroup of our study in which patients underwent a resection of the surrounding gliosis after a preoperative duration of epilepsy of less than 2 years (Group A). There was no mortality, and only minor postoperative neurological deficits occurred in 7.5% of patients.
CONCLUSION: In a long-term follow-up period, 84.9% of the patients in the study could be evaluated as Engel Class I. The analysis of outcome showed that patients benefited significantly from early surgery and excision of the hemosiderin rim.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005379     DOI: 10.1227/01.NEU.0000327881.72964.6E

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  26 in total

1.  Cliniconeuropathologic correlations show astroglial albumin storage as a common factor in epileptogenic vascular lesions.

Authors:  Anna Raabe; Ann Kristin Schmitz; Katharina Pernhorst; Alexander Grote; Christian von der Brelie; Horst Urbach; Alon Friedman; Albert J Becker; Christian E Elger; Pitt Niehusmann
Journal:  Epilepsia       Date:  2012-03       Impact factor: 5.864

2.  Epilepsy Surgeons, Rather than Vascular Neurosurgeons, Should Operate on Cavernous Malformations that Cause Seizures-A Modest Proposal.

Authors:  Theodore H Schwartz
Journal:  Epilepsy Curr       Date:  2010-05       Impact factor: 7.500

3.  Surgery for epilepsy.

Authors:  Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton
Journal:  Cochrane Database Syst Rev       Date:  2019-06-25

Review 4.  Cavernous malformations: natural history, diagnosis and treatment.

Authors:  Sachin Batra; Doris Lin; Pablo F Recinos; Jun Zhang; Daniele Rigamonti
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

Review 5.  Should we resect peri-lesional hemosiderin deposits when performing lesionectomy in patients with cavernoma-related epilepsy (CRE)?

Authors:  P Dammann; C Schaller; U Sure
Journal:  Neurosurg Rev       Date:  2016-11-08       Impact factor: 3.042

Review 6.  Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review.

Authors:  Peter G Campbell; Pascal Jabbour; Sanjay Yadla; Issam A Awad
Journal:  Neurosurg Focus       Date:  2010-09       Impact factor: 4.047

7.  Patient-assessed satisfaction and outcome after microsurgical resection of cavernomas causing epilepsy.

Authors:  Jamie J Van Gompel; W Richard Marsh; Fredric B Meyer; Gregory A Worrell
Journal:  Neurosurg Focus       Date:  2010-09       Impact factor: 4.047

Review 8.  Rates and predictors of seizure freedom in resective epilepsy surgery: an update.

Authors:  Dario J Englot; Edward F Chang
Journal:  Neurosurg Rev       Date:  2014-02-05       Impact factor: 3.042

9.  Seizure risk from cavernous or arteriovenous malformations: prospective population-based study.

Authors:  C B Josephson; J-P Leach; R Duncan; R C Roberts; C E Counsell; R Al-Shahi Salman
Journal:  Neurology       Date:  2011-05-03       Impact factor: 9.910

10.  Surgical management of cavernous malformations presenting with drug-resistant epilepsy.

Authors:  Mario Arturo Alonso-Vanegas; José M Cisneros-Franco; Taisuke Otsuki
Journal:  Front Neurol       Date:  2012-01-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.